Britain’s main doctors’ organisation says it is concerned about the UK’s decision to give people a second dose of coronavirus vaccine up to 12 weeks after the first, rather than the shorter gap recommended by manufacturers and the World Health Organization (WHO).
Also read: Pfizer vaccine will work against UK, SA COVID-19 variants: Study
The UK, which has Europe’s deadliest coronavirus outbreak, adopted the policy in order to give as many people a first dose of the vaccine as quickly as possible. So far almost 5.5 million people have received a first dose of either a vaccine made by Pfizer and BioNTech or one developed by AstraZeneca and Oxford University.
AstraZeneca has said it believes a dose of its vaccine offers protection after 12 weeks, but Pfizer says it has not tested the efficacy of its jab after such a long gap.
Also read: People with history of allergic reactions should avoid Pfizer’s COVID dose: UK
The British Medical Association urged England’s chief medical officer to urgently review the policy for the Pfizer vaccine. It says there was growing concern from the medical profession regarding the delay of the second dose of the Pfizer-BioNTech vaccine as the UK’s strategy has become increasingly isolated from many other countries. Pfizer says its second dose should take place 21 days after the first. The WHO says the second shots of coronavirus vaccines can been given up to six weeks after the first.
(Except for the headline, this story has not been edited by The Federal staff and is auto-published from a syndicated feed.)